Kidney stone disease: pathophysiology, investigation and medical treatment.
作者信息
Dawson Charlotte H, Tomson Charles R V
机构信息
University Hospitals Bristol NHS Foundation Trust.
出版信息
Clin Med (Lond). 2012 Oct;12(5):467-71. doi: 10.7861/clinmedicine.12-5-467.
Abstract
摘要
相似文献
1
Kidney stone disease: pathophysiology, investigation and medical treatment.
Clin Med (Lond). 2012 Oct;12(5):467-71. doi: 10.7861/clinmedicine.12-5-467.
2
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Scand J Urol. 2020 Dec;54(6):456-462. doi: 10.1080/21681805.2020.1840430. Epub 2020 Nov 13.
3
Calcium oxalate kidney stones: another reason to encourage moderate calcium intakes and other dietary changes.
Urol Nurs. 2003 Aug;23(4):310-3.
4
[Renal calcium excretion and urolithiasis].
Clin Calcium. 2011 Oct;21(10):1465-72.
5
The growing prevalence of kidney stones and opportunities for prevention.
R I Med J (2013). 2014 Dec 2;97(12):31-4.
6
[Metaphylaxis of recurrent renal calcium stones].
Ther Umsch. 2007 May;64(5):253-8. doi: 10.1024/0040-5930.64.5.253.
7
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
8
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
BJU Int. 2009 Mar;103(5):670-8. doi: 10.1111/j.1464-410X.2008.08064.x. Epub 2008 Sep 12.
9
Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.
Int Urol Nephrol. 2012 Jun;44(3):857-63. doi: 10.1007/s11255-011-9953-6. Epub 2011 Apr 20.
10
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
QJM. 2015 Jul;108(7):561-8. doi: 10.1093/qjmed/hcu251. Epub 2014 Dec 17.
引用本文的文献
1
Retrospective study on pain management pathway for patients with suspected renal/ ureteric colic in a U.K. accidents and emergency department: A quality improvement project.
F1000Res. 2024 Sep 12;13:1052. doi: 10.12688/f1000research.152325.1. eCollection 2024.
2
History of Renal Stone Surgery: A Narrative Review.
Cureus. 2024 Nov 26;16(11):e74530. doi: 10.7759/cureus.74530. eCollection 2024 Nov.
3
Hydroxyproline increases inflammation and Uropathogenic E. coli (UPEC) infection in female rats.
Sci Rep. 2024 Sep 27;14(1):22237. doi: 10.1038/s41598-024-73246-6.
4
The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493 Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither Increased Risks of Kidney Stones nor Atherosclerosis.
Nutrients. 2024 Jul 12;16(14):2251. doi: 10.3390/nu16142251.
5
Relationship between remnant cholesterol and risk of kidney stones in U.S. Adults: a 2007-2016 NHANES analysis.
Ann Med. 2024 Dec;56(1):2319749. doi: 10.1080/07853890.2024.2319749. Epub 2024 May 11.
6
Tranexamic acid for percutaneous nephrolithotomy.
Cochrane Database Syst Rev. 2023 Oct 26;10(10):CD015122. doi: 10.1002/14651858.CD015122.pub2.
7
Chemical Studies of Multicomponent Kidney Stones Using the Modern Advanced Research Methods.
Molecules. 2023 Aug 16;28(16):6089. doi: 10.3390/molecules28166089.
8
Prevalence and Risk Factors of Renal Stones Among the Bisha Population, Saudi Arabia.
Cureus. 2023 Jun 7;15(6):e40090. doi: 10.7759/cureus.40090. eCollection 2023 Jun.
9
Efficacy and safety of various endosurgical procedures for management of large renal stone: a systemic review and network meta-analysis of randomised control trials.
Urolithiasis. 2023 Jun 8;51(1):87. doi: 10.1007/s00240-023-01459-x.
10
GeoBioMed perspectives on kidney stone recurrence from the reactive surface area of SWL-derived particles.
Sci Rep. 2022 Nov 1;12(1):18371. doi: 10.1038/s41598-022-23331-5.
本文引用的文献
1
A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis.
J Clin Endocrinol Metab. 2012 May;97(5):E840-4. doi: 10.1210/jc.2011-1528. Epub 2012 Mar 14.
2
Hyperoxaluria: a gut-kidney axis?
Kidney Int. 2011 Dec;80(11):1146-58. doi: 10.1038/ki.2011.287. Epub 2011 Aug 24.
3
Ambient temperature as a contributor to kidney stone formation: implications of global warming.
Kidney Int. 2011 Jun;79(11):1178-85. doi: 10.1038/ki.2011.76. Epub 2011 Mar 30.
4
Genetics and calcium nephrolithiasis.
Kidney Int. 2011 Sep;80(6):587-93. doi: 10.1038/ki.2010.430. Epub 2010 Oct 20.
5
An update and practical guide to renal stone management.
Nephron Clin Pract. 2010;116(3):c159-71. doi: 10.1159/000317196. Epub 2010 Jul 2.
6
Comparison of Metabolic Risk Factors in Urolithiasis Patients according to Family History.
Korean J Urol. 2010 Jan;51(1):50-3. doi: 10.4111/kju.2010.51.1.50. Epub 2010 Jan 21.
7
Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region.
Nephrol Dial Transplant. 2010 Jul;25(7):2245-52. doi: 10.1093/ndt/gfp760. Epub 2010 Jan 12.
8
Hypocitraturia: pathophysiology and medical management.
Rev Urol. 2009 Summer;11(3):134-44.
9
Recent Advances in Knowledge Relating to the Formation, Recognition and Treatment of Kidney Calculi.
Bull N Y Acad Med. 1944 Sep;20(9):473-84.
10
Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.
Zotero 插件